JAZZ logo

Jazz Pharmaceuticals (JAZZ) Total debt

Annual Total Debt:

$6.16B+$370.74M(+6.40%)
December 31, 2024

Summary

  • As of today (May 21, 2025), JAZZ annual total debt is $6.16 billion, with the most recent change of +$370.74 million (+6.40%) on December 31, 2024.
  • During the last 3 years, JAZZ annual total debt has risen by +$9.45 million (+0.15%).
  • JAZZ annual total debt is now at all-time high.

Performance

JAZZ Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

Quarterly Total Debt:

$5.42B-$742.65M(-12.05%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ quarterly total debt is $5.42 billion, with the most recent change of -$742.65 million (-12.05%) on March 1, 2025.
  • Over the past year, JAZZ quarterly total debt has dropped by -$365.30 million (-6.31%).
  • JAZZ quarterly total debt is now -21.63% below its all-time high of $6.92 billion, reached on June 30, 2021.

Performance

JAZZ Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

JAZZ Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.4%-6.3%
3 y3 years+0.1%-11.5%
5 y5 years+247.9%+206.2%

JAZZ Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+6.4%-12.6%at low
5 y5-yearat high+247.9%-21.6%+206.2%
alltimeall timeat high>+9999.0%-21.6%>+9999.0%

JAZZ Total debt History

DateAnnualQuarterly
Mar 2025
-
$5.42B(-12.1%)
Dec 2024
$6.16B(+6.4%)
$6.16B(-0.6%)
Sep 2024
-
$6.20B(+7.1%)
Jun 2024
-
$5.79B(+0.1%)
Mar 2024
-
$5.79B(-0.1%)
Dec 2023
$5.79B(-0.4%)
$5.79B(-0.0%)
Sep 2023
-
$5.79B(-0.1%)
Jun 2023
-
$5.80B(-0.2%)
Mar 2023
-
$5.81B(-0.0%)
Dec 2022
$5.81B(-5.5%)
$5.81B(-0.0%)
Sep 2022
-
$5.81B(-4.9%)
Jun 2022
-
$6.11B(-0.1%)
Mar 2022
-
$6.12B(-0.5%)
Dec 2021
$6.15B(+173.5%)
$6.15B(-3.6%)
Sep 2021
-
$6.38B(-7.7%)
Jun 2021
-
$6.92B(+207.1%)
Mar 2021
-
$2.25B(+0.1%)
Dec 2020
$2.25B(+27.0%)
$2.25B(+0.3%)
Sep 2020
-
$2.24B(-0.8%)
Jun 2020
-
$2.26B(+27.7%)
Mar 2020
-
$1.77B(-0.1%)
Dec 2019
$1.77B(+10.9%)
$1.77B(+0.1%)
Sep 2019
-
$1.77B(+0.2%)
Jun 2019
-
$1.77B(+0.3%)
Mar 2019
-
$1.76B(+10.3%)
Dec 2018
$1.60B(+1.0%)
$1.60B(+0.2%)
Sep 2018
-
$1.59B(+0.1%)
Jun 2018
-
$1.59B(+0.6%)
Mar 2018
-
$1.58B(+0.1%)
Dec 2017
$1.58B(-22.1%)
$1.58B(+0.1%)
Sep 2017
-
$1.58B(-5.5%)
Jun 2017
-
$1.67B(-10.9%)
Mar 2017
-
$1.88B(-7.6%)
Dec 2016
$2.03B(+70.8%)
$2.03B(-7.0%)
Sep 2016
-
$2.18B(+85.2%)
Jun 2016
-
$1.18B(-0.4%)
Mar 2016
-
$1.18B(-0.4%)
Dec 2015
$1.19B(-11.5%)
$1.19B(-7.9%)
Sep 2015
-
$1.29B(-5.6%)
Jun 2015
-
$1.37B(+1.7%)
Mar 2015
-
$1.34B(+0.1%)
DateAnnualQuarterly
Dec 2014
$1.34B(+144.1%)
$1.34B(+0.1%)
Sep 2014
-
$1.34B(+12.1%)
Jun 2014
-
$1.20B(-0.2%)
Mar 2014
-
$1.20B(+117.9%)
Dec 2013
$549.98M(+20.4%)
$549.98M(-0.2%)
Sep 2013
-
$551.14M(-0.2%)
Jun 2013
-
$552.30M(+22.4%)
Mar 2013
-
$451.16M(-1.2%)
Dec 2012
$456.76M(>+9900.0%)
$456.76M(-1.2%)
Sep 2012
-
$462.35M(-1.2%)
Jun 2012
-
$467.94M(>+9900.0%)
Mar 2012
-
$0.00(0.0%)
Dec 2011
$0.00(-100.0%)
$0.00(0.0%)
Sep 2011
-
$0.00(-100.0%)
Jun 2011
-
$36.69M(-9.8%)
Mar 2011
-
$40.70M(-15.3%)
Dec 2010
$48.04M(-61.3%)
$48.04M(>+9900.0%)
Sep 2010
-
$0.00(-100.0%)
Jun 2010
-
$48.62M(-59.7%)
Mar 2010
-
$120.55M(-3.0%)
Dec 2009
$124.27M(+1.5%)
$124.27M(+5.0%)
Sep 2009
-
$118.36M(-8.6%)
Jun 2009
-
$129.48M(-3.8%)
Mar 2009
-
$134.63M(+10.0%)
Dec 2008
$122.41M(+55.8%)
$122.41M(+4.7%)
Sep 2008
-
$116.88M(-2.4%)
Jun 2008
-
$119.80M(+2.8%)
Mar 2008
-
$116.55M(+48.3%)
Dec 2007
$78.58M(+2.7%)
$78.58M(+1.4%)
Sep 2007
-
$77.46M(-0.4%)
Jun 2007
-
$77.76M(+0.3%)
Mar 2007
-
$77.53M(+1.4%)
Dec 2006
$76.47M(+3.9%)
$76.47M(>+9900.0%)
Sep 2006
-
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
Mar 2006
-
$0.00(-100.0%)
Dec 2005
$73.63M(>+9900.0%)
$73.63M(>+9900.0%)
Sep 2005
-
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
Mar 2005
-
$0.00
Dec 2004
$0.00
-

FAQ

  • What is Jazz Pharmaceuticals annual total debt?
  • What is the all time high annual total debt for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual total debt year-on-year change?
  • What is Jazz Pharmaceuticals quarterly total debt?
  • What is the all time high quarterly total debt for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly total debt year-on-year change?

What is Jazz Pharmaceuticals annual total debt?

The current annual total debt of JAZZ is $6.16B

What is the all time high annual total debt for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual total debt is $6.16B

What is Jazz Pharmaceuticals annual total debt year-on-year change?

Over the past year, JAZZ annual total debt has changed by +$370.74M (+6.40%)

What is Jazz Pharmaceuticals quarterly total debt?

The current quarterly total debt of JAZZ is $5.42B

What is the all time high quarterly total debt for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly total debt is $6.92B

What is Jazz Pharmaceuticals quarterly total debt year-on-year change?

Over the past year, JAZZ quarterly total debt has changed by -$365.30M (-6.31%)
On this page